Evidence map›Paper›PMID 34675420›Full record

ArticleNature chemical biology2021

Bright and stable luminescent probes for target engagement profiling in live cells.

N Connor Payne, Alena S Kalyakina, Kritika Singh, Mark A Tye, Ralph Mazitschek

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Review
  3. International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Chemical and Enzymatic Approaches to C-Terminal Cyclic Imide Formation.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Genesis and regulation of C-terminal cyclic imides from protein damage.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Review
  18. Article
  19. Identification of a Polypeptide Inhibitor ofJournal of the American Chemical Society · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

N Connor PayneCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9513-6194
Alena S KalyakinaCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1685-8151
Kritika SinghCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-5168-9176
Mark A TyeCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9456-0767
Ralph MazitschekCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, USA. ralph@broad.harvard.edu.ORCID http://orcid.org/0000-0002-1105-689X
Harvard University · USBroad Institute · USKarlsruhe Institute of Technology · DENortheastern University · US

Funding

Proline homeostasis: a novel mediator of drug tolerance in Plasmodium falciparumR01AI143723 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI MAZITSCHEK, RALPH, WIRTH, DYANN F · 2020 to 2024
$3.4M
NIAID NIH HHS R01 AI143723
6 · The paper itself

Abstract

The pace of progress in biomedical research directly depends on techniques that enable the quantitative interrogation of interactions between proteins and other biopolymers, or with their small-molecule ligands. Time-resolved Förster resonance energy transfer (TR-FRET) assay platforms offer high sensitivity and specificity. However, the paucity of accessible and biocompatible luminescent lanthanide complexes, which are essential reagents for TR-FRET-based approaches, and their poor cellular permeability have limited broader adaptation of TR-FRET beyond homogeneous and extracellular assay applications. Here, we report the development of CoraFluors, a new class of macrotricyclic terbium complexes, which are synthetically readily accessible, stable in biological media and exhibit photophysical and physicochemical properties that are desirable for biological studies. We validate the performance of CoraFluors in cell-free systems, identify cell-permeable analogs and demonstrate their utility in the quantitative domain-selective characterization of Keap1 ligands, as well as in isoform-selective target engagement profiling of HDAC1 inhibitors in live cells.

Indexed as

Fluorescence Resonance Energy TransferCoordination ComplexesFluorescent DyesHEK293 CellsHumansKelch-Like ECH-Associated Protein 1Molecular StructureCoordination ComplexesFluorescent DyesKEAP1 protein, humanKelch-Like ECH-Associated Protein 1

Identifiers

PMID34675420
PMCPMC8555866
OpenAlexW3205042410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.